Stress Urinary Incontinence Clinical Trial
Official title:
Clinical and Quality-of-Life Outcomes After Autologous Fascial Sling and Tension-Free Vaginal Tape: a Prospective Randomized Trial
The objective of the study was to evaluate the impact AFS and TVT procedures on quality-of-life in incontinent women.
Between January 2001 to March 2002, 41 women with a principal complaint of stress urinary
incontinence were studied in a prospective trial. Based on results of no numerical variables
(including patient's perception of improvement and satisfaction with treatment), the
statistical test demonstrated the need for equal sized groups for the comparison. So, the
total size of sample groups was previously established as at least 40 women.
These patients were randomly distributed, in a single-blind study, into two groups. Group G1
(n=21) was submitted to AFS and Group G2 (n=20) to TVT implant. Average age in G1 was 49
years (range 26-69), and in G2, 52 years (range 26-79). This study was approved by the
Bioethics Commission of the School of Medicine - UNESP, Botucatu.
All the women underwent preoperative urodynamic study, using a Dynograph R.611 recorder,
which confirmed stress urinary incontinence in all of them. Patients with involuntary
detrusor contractions or preexisting bladder outlet obstruction (BOO) during urodynamic
study were excluded of the study.
The clinical follow up and a subjective success rate was performed at 1, 6, and 12 months
and then annually after hospital discharge. A questionnaire was used to obtain personal
data, obstetric, gynecologic, family history, and subjective analysis of urine loss. Cure
was defined as complete dryness with no usage of pads.
De novo urgency was considered when patients had no problem with urgency symptoms
preoperatively presented these complaints after surgery persisting more than 1 month. These
symptoms were based on clinical evaluation.
Long-term patients' satisfaction and impact on QoL were performed at 36 months after
surgery. To evaluate the QoL a validated questionnaire (11) (King's Health Questionnaire)
was used. Follow up range from 36 to 54 months (median: 44 months).
Body mass index (BMI) was calculated and classified according to Garrow. All patients
underwent physical examination including stress test. The degree of pelvic organ prolapse
was assessed and graded according to Baden et al.
Basal laboratory investigations (serum creatinine, complete blood count, chemical and
microscopic urinalysis, urine culture) were all routinely performed. In exceptional cases
(lithiasis history, urinary infection ) renal ultrasound and plain x-ray of the kidney,
ureters and bladder were carried out.
In the immediate postoperative, endovenous tramadol (10 mg/mL-1) was used in patient
controlled analgesia (PCA) pump. After an i.v. loading dose of 0.07 mL/Kg-1 (administered
over a period of 30 min).
The Physiotherapy Service at each surgical procedure was responsible for carrying out the
random assignment of patients in accordance with the casualty.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04829357 -
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
|
||
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT04512053 -
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
|
Phase 2 | |
Active, not recruiting |
NCT06224335 -
Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)
|
||
Recruiting |
NCT05304312 -
The Role of Kegel Exercises Book to Improve Treatment in Stress Urinary Incontinence Women
|
N/A | |
Not yet recruiting |
NCT05527665 -
Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
|
||
Not yet recruiting |
NCT04558762 -
Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence
|
||
Withdrawn |
NCT02524366 -
A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
|
N/A | |
Completed |
NCT01924728 -
Efficacy of Magnetic Stimulation for Stress Urinary Incontinence
|
N/A | |
Completed |
NCT01676662 -
Solace European Confirmatory Trial
|
N/A | |
Unknown status |
NCT01455779 -
Lyrette: Renewing Continence Objective and Subjective Efficacy Study
|
N/A | |
Terminated |
NCT01029106 -
Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)
|
N/A | |
Completed |
NCT01770691 -
Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence
|
N/A | |
Completed |
NCT01123096 -
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
|
N/A | |
Withdrawn |
NCT00573703 -
Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence
|
Phase 4 | |
Completed |
NCT00234754 -
Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women
|
N/A | |
Completed |
NCT00441454 -
Retropubic vs. Transobturator Tension-free Vaginal Tape
|
N/A | |
Completed |
NCT03985345 -
Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence.
|
N/A | |
Active, not recruiting |
NCT03671694 -
Laser Vaginal Treatment for SUI
|
N/A | |
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 |